| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in NBIX over the last quarter tilts toward selling: insiders offloaded a net 6,541 shares worth roughly $1.1M.
Classified under Pharmaceuticals (Health Care sector), NBIX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 517.8K | $80.89M | - | |
| CEO | 154.7K | $24.17M | - | |
| Other | 67.3K | $10.51M | - | |
| Other | 56.8K | $8.87M | - | |
| CFO | 42.8K | $6.73M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 25, 2022 | Lyons Gary A54 | Director | Sale+OE | 15,000 | $92.76 | $1,391,392.50 | -6.7% | +1.6% | +9.2% | |
| Apr 1, 2022 | Rastetter William H48 | Director | Sale+OE | 10,728 | $94.93 | $1,018,366.13 | -24.0% | +2.0% | +5.9% | |
| Mar 22, 2022 | Lippoldt Darin60 | Chief Legal Officer | Sell | 8,755 | $95.05 | $832,156.21 | -22.9% | -1.5% | +0.4% | |
| Feb 8, 2022 | Gorman Kevin Charles55 | Chief Executive Officer | Sell | 10,984 | $80.54 | $884,674.32 | -2.3% | -5.2% | +30.7% | |
| Feb 8, 2022 | Benevich Eric62 | Chief Commercial Officer | Sell | 5,099 | $80.57 | $410,820.89 | -20.0% | -5.2% | +30.7% | |
| Feb 8, 2022 | Cooke Julie59 | Chief Human Resources Officer | Sell | 2,858 | $80.38 | $229,727.32 | -14.1% | -5.2% | +30.7% | |
| Feb 8, 2022 | Gano Kyle54 | Chief Business Development Off | Sell | 6,880 | $80.61 | $554,627.74 | -5.8% | -5.2% | +30.7% | |
| Feb 8, 2022 | Lippoldt Darin60 | Chief Legal Officer | Sell | 4,079 | $80.45 | $328,159.81 | -9.7% | -5.2% | +30.7% | |
| Feb 8, 2022 | Lloyd-Smith Malcolm49 | Chief Regulatory Officer | Sell | 3,382 | $80.48 | $272,167.90 | -15.3% | -5.2% | +30.7% | |
| Feb 8, 2022 | Roberts Eiry49 | Chief Medical Officer | Sell | 3,724 | $80.45 | $299,590.39 | -13.1% | -5.2% | +30.7% |